Hoth Therapeutics logo

Hoth Therapeutics share price today

(HOTH)

Hoth Therapeutics share price is $0.81 & ₹68.83 as on 21 Dec 2024, 2.30 'hrs' IST

$0.81

0.04

(5.21%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Hoth Therapeutics share price in Dollar and Rupees. Guide to invest in Hoth Therapeutics from India. Also see the sentimental analysis on Indian investors investing in Hoth Therapeutics. Get details on the Indian mutual funds that are investing in Hoth Therapeutics. Get Analyst recommendations and forecasts along with all the Hoth Therapeutics's financials.

Hoth Therapeutics share price movements

  • Today's Low: $0.73
    Today's High: $0.82

    Day's Volatility :10.96%

  • 52 Weeks Low: $0.58
    52 Weeks High: $1.73

    52 Weeks Volatility :66.47%

Hoth Therapeutics Returns

PeriodHoth Therapeutics IncIndex (Russel 2000)
3 Months
-11.31%
0.0%
6 Months
-12.92%
0.0%
1 Year
-40.0%
0.0%
3 Years
-95.68%
-19.7%

Hoth Therapeutics Key Statistics

in dollars & INR

Previous Close
$0.7699
Open
$0.7593
Today's High
$0.8199
Today's Low
$0.73
Market Capitalization
$5.3M
Today's Volume
$152.7K
52 Week High
$1.73
52 Week Low
$0.58
Revenue TTM
$0.0
EBITDA
$-14.1M
Earnings Per Share (EPS)
$-1.27
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-83.41%

How to invest in Hoth Therapeutics from India?

It is very easy for Indian residents to invest directly in Hoth Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Hoth Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Hoth Therapeutics or HOTH on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Hoth Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Hoth Therapeutics shares which would translate to 1.049 fractional shares of Hoth Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Hoth Therapeutics, in just a few clicks!

Returns in Hoth Therapeutics for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Hoth Therapeutics investment value today

Current value as on today

₹1,42,196

Returns

₹42,196

(+42.2%)

Returns from Hoth Therapeutics Stock

₹40,000 (false-40%)

Dollar Returns

₹2,196 (+2.2%)

Indian investors sentiment towards Hoth Therapeutics

46%

Period: Sep 21, 2024 to Dec 20, 2024. Change in 30 Days versus previous period

Search volume for Hoth Therapeutics on INDmoney from India has grown in the last 30 days as on Dec 21, 2024. 46% more investors are searching Hoth Therapeutics in the last 30 days versus the previous period.

Global Institutional Holdings in Hoth Therapeutics

  • HRT FINANCIAL LLC

    1.77%

  • Geode Capital Management, LLC

    1.20%

  • UBS Group AG

    0.82%

  • Vanguard Group Inc

    0.56%

  • TWO SIGMA SECURITIES, LLC

    0.27%

  • Morgan Stanley - Brokerage Accounts

    0.15%

Analyst Recommendation on Hoth Therapeutics

Buy

    87%Buy

    12%Hold

    0%Sell

Based on 8 Wall street analysts offering stock ratings for Hoth Therapeutics(by analysts ranked 0 to 5 stars)

Based on 8 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
7
8
7
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Hoth Therapeutics

What analysts predicted

Upside of 455.56%

Current:

$0.81

Target:

$4.50

Insights on Hoth Therapeutics

  • Price Movement

    In the last 3 years, HOTH stock has moved down by -95.6%
  • HOTH vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 35.5% return, outperforming this stock by 66.3%
  • HOTH vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 23.0% return, outperforming this stock by 118.6%

Hoth Therapeutics Technicals Summary

Sell

Neutral

Buy

Hoth Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Hoth Therapeutics Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Hoth Therapeutics Inc
-2.5%
-12.92%
-40.0%
-95.68%
-99.38%
Regeneron Pharmaceuticals, Inc.
-5.73%
-34.03%
-17.11%
13.66%
87.56%
Biontech Se
4.48%
30.56%
7.36%
-56.46%
225.6%
Alnylam Pharmaceuticals, Inc.
-0.55%
10.11%
28.49%
30.99%
109.19%
Vertex Pharmaceuticals Incorporated
-11.79%
-16.36%
-1.97%
78.33%
80.59%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Hoth Therapeutics Inc
NA
NA
NA
-1.54
-0.83
-0.46
NA
1.09
Regeneron Pharmaceuticals, Inc.
17.51
17.51
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.17
0.55
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Hoth Therapeutics Inc
Buy
$5.3M
-99.38%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$77.8B
87.56%
17.51
33.61%
Biontech Se
Buy
$26.7B
225.6%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.8B
109.19%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$102.1B
80.59%
32.84
-4.51%

About Hoth Therapeutics

hoth therapeutics, inc., a biopharmaceutical company, focuses on developing therapies for dermatological disorders. the company focuses on therapies for patients suffering from indications, including eczema, chronic wounds, psoriasis, asthma, and acne. it intends to use the biolexa platform to develop two topical cream products that treat eczema and reduces post-procedure infections for patients undergoing aesthetic dermatology procedures. the company has license agreements with the george washington university; the university of maryland baltimore; isoprene pharmaceuticals, inc.; the north carolina state university; chelexa biosciences, inc.; and the university of cincinnati. it also has a partnership agreement with zyl㶠therapeutics inc. co-develop a new topical treatment for patients with cutaneous lupus erythematosu, a chronic autoimmune disease that affects the skin and is associated with a significant burden on patient quality of life. hoth therapeutics has research collaboratio
Organization
Hoth Therapeutics
Employees
2
CEO
Mr. Robb Knie
Industry
Pharmaceuticals: Major

Management People of Hoth Therapeutics

NameTitle
Mr. Robb Knie
Founder, President, CEO & Chairman
Mr. David S. Briones
Chief Financial Officer
Ms. Hayley Springer
Executive Vice President of Operations

Important FAQs about investing in Hoth Therapeutics from India :

What is Hoth Therapeutics share price today?

Hoth Therapeutics share price today stands at $0.81, Open: $0.76 ; Previous Close: $0.77 ; High: $0.82 ; Low: $0.73 ; 52 Week High: $1.73 ; 52 Week Low: $0.58. The stock opens at $0.76, after a previous close of $0.77. The stock reached a daily high of $0.82 and a low of $0.73, with a 52-week high of $1.73 and a 52-week low of $0.58.

Can Indians buy Hoth Therapeutics shares?

Yes, Indians can invest in the Hoth Therapeutics (HOTH) from India.

With INDmoney, you can buy Hoth Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Hoth Therapeutics at zero transaction cost.

How can I buy Hoth Therapeutics shares from India?

It is very easy to buy Hoth Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Hoth Therapeutics be purchased?

Yes, you can buy fractional shares of Hoth Therapeutics with INDmoney app.

What are the documents required to start investing in Hoth Therapeutics stocks?

To start investing in Hoth Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Hoth Therapeutics

Today’s highest price of Hoth Therapeutics (HOTH) is $0.82.

Today’s lowest price of Hoth Therapeutics (HOTH) is $0.73.

What is today's market capitalisation of Hoth Therapeutics

Today's market capitalisation of Hoth Therapeutics HOTH is 5.3M

What is the 52 Week High and Low Range of Hoth Therapeutics

  • 52 Week High

    $1.73

  • 52 Week Low

    $0.58

What are the historical returns of Hoth Therapeutics?

  • 1 Month Returns

    -2.5%

  • 3 Months Returns

    -12.92%

  • 1 Year Returns

    -40%

  • 5 Years Returns

    -99.38%

Who is the Chief Executive Officer (CEO) of Hoth Therapeutics

Mr. Robb Knie is the current Chief Executive Officer (CEO) of Hoth Therapeutics.